
    
      All participants received a total of 9 injections during the study. Vaccine immunogenicity
      assessments for dengue neutralizing antibodies was performed in a randomized subset of
      participants. All participants were followed-up for safety during the study and for 6 months
      after the last CYD dengue vaccination.
    
  